Mission: The team of top research scientists at the Institute for Myeloma & Bone Cancer Research utilize years of cumulative expertise and innovative technologies to drive the independent research of the Institute. By using in vitro as well as in vivo research techniques, our scientists have the potential to greatly improve and expand the types of drugs for patients with these diseases as well as rapidly lead to many clinical trials to achieve our mission.
Results: Our team understands the science and how to apply it to patients. We have amassed decades of experience in our ability to outsmart the disease and find inroads to fight these cancers on many innovative levels. The motivation to build the Institute for Myeloma & Bone Cancer Research comes from the core belief that a dedicated, stand-alone organization can accelerate the advancement of scientific research and ultimately help grant millions of people freedom from the symptoms of these devastating diseases.
Programs: Achieved advancements in the research and cure for myeloma. Research has helped cure or reduce the occurrence of myeloma in humans.
The Institute for Myeloma and Bone Cancer Research is a extremely helpful organization. Under the knowledgeable hand of Dr. James Berenson, the institute conducts ground-breaking research on new drugs and drug combinations, understanding the complex mechanisms involved in the myeloma progression and developing therapies that are tailored to the genetic profile of myeloma patients. Moreover, the institute has a large outreach function, producing informational videos and media interviews that relate important information to myeloma patients around the world. The Institute for Myeloma and Bone Cancer Research is a vital platform to help research and treat this difficult disease while improving the quality of life of myeloma patients everywhere.